Cargando…
Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal
Interest in amyotrophic lateral sclerosis (ALS) biomarkers has grown exponentially over the course of the last 25 years, with great hope that they might serve as tools to facilitate the development of meaningful therapies for this otherwise inexorably progressive and invariably fatal disease. Effect...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316774/ https://www.ncbi.nlm.nih.gov/pubmed/36310538 http://dx.doi.org/10.1093/brain/awac394 |